drugset / Trial / NCT00306163

Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)

NCT00306163

Phase 3 Completed 37 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to compare the responsiveness of lower airways in adult patients with stable asthma after treatment with ciclesonide and fluticasone propionate. Treatment medication will be administered as follows: ciclesonide will be inhaled once daily at one dose level, fluticasone propionate will be inhaled twice daily at one dose level. The study duration consists of a baseline period (5 weeks) and a treatment period (5 weeks). The study will provide further data on safety and tolerability of ciclesonide.

Timeline

Start
2006-05
Primary completion
2008-08
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciclesonide Other / unclassified 160 ug Inhaled
Comparator Fluticasone Other / unclassified 100 ug Inhaled

Indications